Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Bonnet

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
International Journal of Antimicrobial Agents|February 12, 2019
Use of non-carbapenem antibiotics to treat severe extended-spectrum β-lactamase-producing Enterobacteriaceae infections in intensive care unit patientsCharles-Edouard Luyt, Morgane Faure, Isabelle Bonnet, et al.
Current Oncology (Toronto, Ont.)|April 21, 2022
Outcomes of Patients with Metastatic Castration-Resistant Prostate Cancer According to Somatic Damage DNA Repair Gene AlterationsZoé Neviere, Elodie Coquan, Pierre-Emmanuel Brachet, et al.
Journal of Cell Science|January 26, 2021
Control of SRC molecular dynamics encodes distinct cytoskeletal responses by specifying signaling pathway usageAdèle Kerjouan, Cyril Boyault, Christiane Oddou, et al.
Emerging Infectious Diseases|March 2, 2025
Evaluation of High-Dose Isoniazid in Multidrug-Resistant Tuberculosis TreatmentValentina Gerussi, Tania Petersen, Isabelle Bonnet, et al.
BMC Cancer|November 26, 2022
TALASUR trial: a single arm phase II trial assessing efficacy and safety of TALazoparib and Avelumab as maintenance therapy in platinum-Sensitive metastatic or locally advanced URothelial carcinomaElodie Coquan, Bénédicte Clarisse, Justine Lequesne, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 13, 2025
Quantifying cell traction forces at the single-fiber scale in 3D: An approach based on deformable photopolymerized fiber arraysPierre Ucla, Joanne Lê-Chesnais, Henri Ver Hulst, et al.
Journal of Cosmetic Science|February 22, 2018
Collagen XVIII: A key interfacial component of the skin architectureIsabelle Bonnet, Lara Jobeili, Sébatien Cadau, et al.
Oncotarget|June 23, 2018
Quality of life in cancer patients undergoing anticoagulant treatment with LMWH for venous thromboembolism: the QUAVITEC study on behalf of the Groupe Francophone Thrombose et Cancer (GFTC)Dominique Farge, Francis Cajfinger, Nicolas Falvo, et al.
ACS Infectious Diseases|January 6, 2026
Diaryl-Aminoindazole with Extensive In Vitro Mycobactericidal Activity Dependent on Exposure to Reactive Nitrogen SpeciesThulasi Warrier, María Martínez-Hoyos, Esther Porras De Francisco, et al.
Clinical Colorectal Cancer|January 12, 2016
Feasibility of Capecitabine and Oxaliplatin Combination Chemotherapy Without Central Venous Access Device in Patients With Stage III Colorectal CancerAlexandra Lapeyre-Prost, Marine Hug de Larauze, Benoist Chibaudel, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
International Journal of Antimicrobial Agents|February 12, 2019
Use of non-carbapenem antibiotics to treat severe extended-spectrum β-lactamase-producing Enterobacteriaceae infections in intensive care unit patientsCharles-Edouard Luyt, Morgane Faure, Isabelle Bonnet, et al.
Current Oncology (Toronto, Ont.)|April 21, 2022
Outcomes of Patients with Metastatic Castration-Resistant Prostate Cancer According to Somatic Damage DNA Repair Gene AlterationsZoé Neviere, Elodie Coquan, Pierre-Emmanuel Brachet, et al.
Journal of Cell Science|January 26, 2021
Control of SRC molecular dynamics encodes distinct cytoskeletal responses by specifying signaling pathway usageAdèle Kerjouan, Cyril Boyault, Christiane Oddou, et al.
Emerging Infectious Diseases|March 2, 2025
Evaluation of High-Dose Isoniazid in Multidrug-Resistant Tuberculosis TreatmentValentina Gerussi, Tania Petersen, Isabelle Bonnet, et al.
BMC Cancer|November 26, 2022
TALASUR trial: a single arm phase II trial assessing efficacy and safety of TALazoparib and Avelumab as maintenance therapy in platinum-Sensitive metastatic or locally advanced URothelial carcinomaElodie Coquan, Bénédicte Clarisse, Justine Lequesne, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 13, 2025
Quantifying cell traction forces at the single-fiber scale in 3D: An approach based on deformable photopolymerized fiber arraysPierre Ucla, Joanne Lê-Chesnais, Henri Ver Hulst, et al.
Journal of Cosmetic Science|February 22, 2018
Collagen XVIII: A key interfacial component of the skin architectureIsabelle Bonnet, Lara Jobeili, Sébatien Cadau, et al.
Oncotarget|June 23, 2018
Quality of life in cancer patients undergoing anticoagulant treatment with LMWH for venous thromboembolism: the QUAVITEC study on behalf of the Groupe Francophone Thrombose et Cancer (GFTC)Dominique Farge, Francis Cajfinger, Nicolas Falvo, et al.
ACS Infectious Diseases|January 6, 2026
Diaryl-Aminoindazole with Extensive In Vitro Mycobactericidal Activity Dependent on Exposure to Reactive Nitrogen SpeciesThulasi Warrier, María Martínez-Hoyos, Esther Porras De Francisco, et al.
Clinical Colorectal Cancer|January 12, 2016
Feasibility of Capecitabine and Oxaliplatin Combination Chemotherapy Without Central Venous Access Device in Patients With Stage III Colorectal CancerAlexandra Lapeyre-Prost, Marine Hug de Larauze, Benoist Chibaudel, et al.
Pageof 6